Immune dysfunction in patients with diabetes mellitus (DM)

Deresinski, 1995, Infections in the diabetic patient: Strategies for the clinician, Infect. Dis. Rep., 1, 1

Carton, 1992, Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients, Eur. J. Med., 1, 281

Lederman, 1981, Pneumococcal immunization in adults, Diabetes, 30, 119, 10.2337/diab.30.2.119

Beam, 1980, Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics, J. Am. Med. Assoc., 244, 2641, 10.1001/jama.1980.03310230023016

Volti, 1998, Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus, Arch. Dis. Child., 78, 54, 10.1136/adc.78.1.54

Moutschen, 1992, Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved in relevance to the increased susceptibility of diabetic patients to specific infections, Diabetes Metab., 18, 187

Casey, 1977, Impaired response of lymphocytes of diabetic subjects to antigen of Staphylococcus aureus, J. Infect. Dis., 136, 495, 10.1093/infdis/136.4.495

Maccuish, 1974, Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetics, Diabetes, 23, 708, 10.2337/diab.23.8.708

Plouffe, 1978, Cell-mediated immunity in diabetes mellitus, Infect. Immun., 21, 425, 10.1128/IAI.21.2.425-429.1978

Vergani, 1983, Low serum C4 concentrations: an inherited predisposition to insulin dependent diabetes, Br. Med. J., 286, 926, 10.1136/bmj.286.6369.926

Mysliwska, 1998, Significance of tumor necrosis factor-α in patients with long-standing type-1 diabetes mellitus, Horm. Metab. Res., 30, 158, 10.1055/s-2007-978857

Pickup, 1998, Is type II diabetes mellitus a disease of the innate immune system, Diabetologia, 41, 1241, 10.1007/s001250051058

Zozulinska, 1999, Serum interleukin-8 level is increased in diabetic patients, Diabetologia, 42, 117, 10.1007/s001250051124

Mooradian, 1991, Serum levels of tumor necrosis factor and IL1α and IL-1β in diabetic patients, Diabetes Care, 14, 63, 10.2337/diacare.14.1.63

Ohno, 1993, In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin-dependent diabetes mellitus, J. Clin. Endocrinol. Metab., 77, 1072

Ziegler-Heitbrock, 1994, Tolerance to lipopolysaccharide involves mobilization of nuclear factor kB with predominance of p50 homodimers, J. Biol. Chem., 269, 17001, 10.1016/S0021-9258(17)32510-3

Morohoshi, 1995, The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes, Ann. NY Acad. Sci., 748, 562, 10.1111/j.1749-6632.1994.tb17362.x

Reinhold, 1996, Elevated glucose levels stimulate transforming growth factor-b1 (TGF-B1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells, Horm. Metab. Res., 28, 267, 10.1055/s-2007-979789

Stehouwer, 1997, Endothelial dysfunction and pathogenesis of diabetic angiopathy, Cardiovasc. Res., 34, 55, 10.1016/S0008-6363(96)00272-6

Vlassara, 1988, Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling, Science, 240, 1546, 10.1126/science.3259727

Imani, 1993, Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: Role in tissue remodeling, J. Exp. Med., 178, 2165, 10.1084/jem.178.6.2165

Wahl, 1998, Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification, Lancet, 352, 1012, 10.1016/S0140-6736(98)04055-0

Hostetter, 1990, Perspectives in diabetes. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans, Diabetes, 39, 271, 10.2337/diab.39.3.271

Geerlings, 1999, The effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: Studies using urine from diabetics and non-diabetics, J. Med. Microbiol., 48, 535, 10.1099/00222615-48-6-535

Tater, 1987, Polymorphonuclear cell derangements in type I diabetes, Horm. Metab. Res., 19, 642, 10.1055/s-2007-1011899

Tan, 1975, Neutrophil dysfunction in diabetes mellitus, J. Lab. Clin. Med., 85, 26

Andersen, 1988, Neutrophil adhesive dysfunction in diabetes mellitus; the role of cellular and plasma factors, J. Lab. Clin. Med., 111, 275

Bloomgarden, 1998, Endothelial dysfunction, neuropathy and the diabetic foot, diabetic mastopathy, and erectile dysfunction, Diabetes Care, 21, 183, 10.2337/diacare.21.1.183

Zargar, 1998, Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus, Postgrad. Med. J., 74, 665, 10.1136/pgmj.74.877.665

Wellinghausen, 1996, Zinc enhances lipopolysaccharide-induced monkine secretion by alteration of fluidity state of lipopolysaccharide, J. Immunol., 157, 3139, 10.4049/jimmunol.157.7.3139

Delamaire, 1997, Impaired leucocyte functions in diabetic patients, Diabetic Med., 14, 29, 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V

Mowat, 1971, Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus, New Engl. J. Med., 284, 621, 10.1056/NEJM197103252841201

Balasoiu, 1997, Granulocyte function in women with diabetes and asymptomatic bacteriuria, Diabetes Care, 20, 392, 10.2337/diacare.20.3.392

Bagdade, 1978, Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes, Diabetes, 27, 677, 10.2337/diab.27.6.677

Bagdade, 1980, Impaired granulocyte adherence in mildly diabetic patients. Effects of tolazamide treatment, Diabetes, 29, 309, 10.2337/diab.29.4.309

Marhoffer, 1992, Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes, Diabetes Care, 15, 256, 10.2337/diacare.15.2.256

Gin, 1984, Influence of glycaemic normalisation by an artificial pancreas on phagocytic and bactericidal functions of granulocytes in insulin dependent diabetic patients, J. Clin. Pathol., 37, 1029, 10.1136/jcp.37.9.1029

Saeed, 1998, Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: Implications for diabetic susceptibility to infections, Clin. Diagn. Lab. Immunol., 5, 740, 10.1128/CDLI.5.5.740-743.1998

Shah, 1983, Chemiluminescence and superoxide anion production by leukocytes from diabetic patients, J. Clin. Endocrinol. Metab., 57, 402, 10.1210/jcem-57-2-402

Katz, 1983, Phagocytotic activity of monocytes from diabetic patients, Diabetes Care, 6, 479, 10.2337/diacare.6.5.479

Schaeffer, 1981, Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections, New Engl. J. Med., 304, 1062, 10.1056/NEJM198104303041802

Aly, 1992, Factors influencing oral carriage of yeasts among individuals with diabetes mellitus, Epidemiol. Infect., 109, 507, 10.1017/S0950268800050500

Cameron, 1996, Blood group glycolipids as epithelial cell receptors for Candida albicans, Infect. Immun., 64, 891, 10.1128/IAI.64.3.891-896.1996

Weinmeister, 1994, Buccal cell carbohydrates are altered during critical illness, Am. J. Respir. Crit. Care Med., 150, 131, 10.1164/ajrccm.150.1.8025738

Darwazeh, 1990, The relationship between colonisation, secretor status and in vitro adhesion of Candida albicans to buccal epithelial cells from diabetics, J. Med. Microbiol., 33, 43, 10.1099/00222615-33-1-43